Evnin Luke's Form 4 filing
Werewolf Therapeutics, Inc. (HOWL) · filed Nov 3, 2025
- Accession no.
- 0001134657-25-000004
- Filed
- Nov 3, 2025
- Trade date
- Oct 30-Nov 3, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $251.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Evnin LukeCIK 0001134657 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 30, 2025 | Common Stock | SSaleDisposed | −55,795 | $1.43 | −$79,786.85 | 4,076,920 | Indirect | |
| Oct 31, 2025 | Common Stock | SSaleDisposed | −73,192 | $1.28 | −$93,685.76 | 4,003,728 | Indirect | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −60,369 | $1.29 | −$77,876.01 | 3,943,359 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.